Wellstars investment will provide significant support to KSUs Department of Athletics and its student-athletes
Why just get more sleep rarely works Insomnia is not always a lack of effort
The Company has licensed the rights of its exenatide delivery system, supported by the proprietary NanoPortal platform, to development partner, Okava Pharmaceuticals, which is studying OKV-119 for the treatment of pre-diabetes, diabetes and obesity in companion felines
Heres what we know from the available data thus far: No reported toxicity in preclinical injection studies No behavioral or pathological abnormalities observed No adverse safety signals in topical skin care studies Theoretical concerns about copper overload exist, but no study to date has demonstrated this outcome with GHK-Cu
Insulin glargine U-100 is an analogue with a slower onset of action than NPH and a smoother action profile, with no peaks and action lasting up to 1824h
When your B12 levels are where they should be, you just feel better
